Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > What is link and time date. Can we see it?

<< Previous

Bullboard Posts

Next >>

Comment by longterm56on Aug 20, 2021 10:48am

121 Views

Post# 33739551

RE:RE:What is link and time date. Can we see it?

Can someone explain to me why it is beneficial to *not* have this notice on THTX's website? I'm trusting they considered it and somehow decided it was better NOT to publicize it ... but I'd like to understand their reasoning.

-LT

PWIB123 wrote: I received an email from John Mullaly with the information in the form of a LifeSci Advisors publication. You have to register at https://lifesci.rampard.com/WebcastingAppv5/Events/eventsDispatcher.jsp?Y2lk=MTM1NQ.

IT is Monday, 9/13 at 11:00 a.m. CST or 12:00 p.m. EDT.

<< Previous

Bullboard Posts

Next >>

Quest Diagnostics to acquire LifeLabs from OMERS for C$1.35 billion